Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

55.9K
Overview
55.9K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

144
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
144
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

59
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
59
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

70
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
70
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

58
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
58

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-Atherogenic Actions of Pomegranate Polyphenol Punicalagin and Its Metabolites: In Vitro Effects on Vascular Cells and In Vivo Atheroprotection by Urolithin A via Anti-Inflammatory and Plaque-Stabilising Mechanisms.

Antioxidants (Basel, Switzerland)·2026
Same author

Resveratrol Mediates Anti-Atherogenic Actions In Vitro and in LDL Receptor-Deficient Mice Fed a High-Fat Diet via Antioxidant, Anti-Inflammatory and Plaque-Stabilising Activities.

Antioxidants (Basel, Switzerland)·2026
Same author

Delineation of a thrombin receptor-stimulated vascular smooth muscle cell transition generating cells in the plaque-stabilizing fibrous cap.

Cardiovascular research·2025
Same author

Therapeutic targeting of chronic kidney disease-associated DAMPs differentially contributing to vascular pathology.

Frontiers in immunology·2023
Same author

The Role of Punicalagin and Its Metabolites in Atherosclerosis and Risk Factors Associated with the Disease.

International journal of molecular sciences·2023
Same author

(+)-Catechin Attenuates Multiple Atherosclerosis-Associated Processes In Vitro, Modulates Disease-Associated Risk Factors in C57BL/6J Mice and Reduces Atherogenesis in LDL Receptor Deficient Mice by Inhibiting Inflammation and Increasing Markers of Plaque Stability.

Molecular nutrition & food research·2023

Related Experiment Video

Updated: Oct 1, 2025

In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis
09:43

In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis

Published on: August 4, 2011

18.2K

Probing Inflammasome Activation in Atherosclerosis.

Yee-Hung Chan1, Dipak P Ramji2

  • 1Cardiff School of Biosciences, Cardiff University, Cardiff, UK. ChanYH1@Cardiff.ac.uk.

Methods in Molecular Biology (Clifton, N.J.)
|March 3, 2022
PubMed
Summary

Chronic inflammation drives atherosclerosis via cytokines like Interleukin-1β and Interleukin-18. This study quantifies these key inflammatory markers using ELISA and Western blot after inflammasome activation.

Keywords:
ELISAIL-18IL-1βNLRP3Western blotcholesterol crystalimmunoblottinglipopolysaccharide

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.4K
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

10.9K

Related Experiment Videos

Last Updated: Oct 1, 2025

In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis
09:43

In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis

Published on: August 4, 2011

18.2K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.4K
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

10.9K

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Atherosclerosis pathogenesis involves chronic inflammation, significantly influenced by pro-inflammatory cytokines.
  • Interleukins (IL) play critical roles in atherogenesis by promoting immune cell infiltration, mediator production, and foam cell formation.
  • Stimuli within atherosclerotic plaques, such as oxidized LDL and cholesterol crystals, activate inflammasomes.

Purpose of the Study:

  • To detail methods for quantifying key pro-atherogenic cytokines, Interleukin-1β (IL-1β) and Interleukin-18 (IL-18).
  • To describe the quantification of IL-1β and IL-18 following the activation of the NLRP3 inflammasome in cultured cells.

Main Methods:

  • Quantification of cytokines in cell supernatant using enzyme-linked immunosorbent assay (ELISA).
  • Western blot analysis to measure cytokine levels within cell lysates.
  • Stimulation of inflammasome activation in cultured cells to induce cytokine release.

Main Results:

  • The study outlines the procedures for measuring IL-1β and IL-18 levels.
  • Successful quantification of these cytokines is demonstrated following inflammasome activation.

Conclusions:

  • NLRP3 inflammasome activation leads to the release of IL-1β and IL-18, critical drivers of inflammation in atherosclerosis.
  • ELISA and Western blot are validated methods for quantifying these crucial cytokines in research settings.